U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H34O11
Molecular Weight 534.5523
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ARCTIIN

SMILES

COC1=CC=C(C[C@H]2COC(=O)[C@@H]2CC3=CC(OC)=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C=C3)C=C1OC

InChI

InChIKey=XOJVHLIYNSOZOO-SWOBOCGESA-N
InChI=1S/C27H34O11/c1-33-18-6-4-14(10-20(18)34-2)8-16-13-36-26(32)17(16)9-15-5-7-19(21(11-15)35-3)37-27-25(31)24(30)23(29)22(12-28)38-27/h4-7,10-11,16-17,22-25,27-31H,8-9,12-13H2,1-3H3/t16-,17+,22+,23+,24-,25+,27+/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H34O11
Molecular Weight 534.5523
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18288407 https://www.ncbi.nlm.nih.gov/pubmed/15042601

Arctiin, isolated from Forsythia suspensa has been reported to have anti-inflammatory, anti-oxidant, antibacterial, and antiviral effects in vitro. It has been found to act as agonist of the adiponectin receptor 1. Has a potential role in the treatment of obesity. Arctiin has being shown to have anticancer effects in animal research.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Bioactivity-guided isolation of antiproliferative compounds from Centaurea arenaria.
2010-11
Determination of the major constituents in fruit of Arctium lappa L. by matrix solid-phase dispersion extraction coupled with HPLC separation and fluorescence detection.
2010-10-15
On-line coupling of counter-current chromatography and macroporous resin chromatography for continuous isolation of arctiin from the fruit of Arctium lappa L.
2010-08-13
Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria.
2010-04-16
Mass fragmentation study of the trimethylsilyl derivatives of arctiin, matairesinoside, arctigenin, phylligenin, matairesinol, pinoresinol and methylarctigenin: their gas and liquid chromatographic analysis in plant extracts.
2010-03-05
Metabolic profile of the bioactive compounds of burdock (Arctium lappa) seeds, roots and leaves.
2010-01-20
Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling.
2010-01-04
Dibenzylbutyrolactone lignans from Forsythia koreana fruits attenuate lipopolysaccharide-induced inducible nitric oxide synthetase and cyclooxygenase-2 expressions through activation of nuclear factor-κb and mitogen-activated protein kinase in RAW264.7 cells.
2010
Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus.
2010
Bioassay-guided isolation and identification of active compounds from Fructus Arctii against Dactylogyrus intermedius (Monogenea) in goldfish (Carassius auratus).
2009-12
Ameliorative effects of arctiin from Arctium lappa on experimental glomerulonephritis in rats.
2009-11
Further studies on a human intestinal bacterium Ruminococcus sp. END-1 for transformation of plant lignans to mammalian lignans.
2009-08-26
Natural Arctium lappa fruit extract improves the clinical signs of aging skin.
2008-12
In vitro and in vivo anti-allergic effects of Arctium lappa L.
2008-11
Treatment with SI000413, a new herbal formula, ameliorates murine collagen-induced arthritis.
2008-07
Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
2008-03
Microemulsion electrokinetic chromatography for the separation of arctiin and arctigenin in Fructus Arctii and its herbal preparations.
2007-12-01
The chemopreventive effects of Saussurea salicifolia through induction of apoptosis and phase II detoxification enzyme.
2007-12
Inhibitory effect of nordihydroguaiaretic acid, a plant lignan, on Helicobacter pylori-associated gastric carcinogenesis in Mongolian gerbils.
2007-11
Isolation and characterization of a human intestinal bacterium, Eubacterium sp. ARC-2, capable of demethylating arctigenin, in the essential metabolic process to enterolactone.
2007-05
A new lignan glycoside from the stem bark of Styrax japonica S. et Z.
2007-04
Antiviral activity of berberine and related compounds against human cytomegalovirus.
2007-03-15
[Relative adscriptions of components in the effective fractions of Yinqiao decoction and its composing individual herbs].
2007-02
In-vitro and in-vivo anti-inflammatory action of the ethanol extract of Trachelospermi caulis.
2007-01
Lack of a significant effect of arctiin on development of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats.
2007
Americanin, a bioactive dibenzylbutyrolactone lignan, from the seeds of Centaurea americana.
2006-11
[Study on condition for extraction of arctiin from fruits of Arctium lappa using supercritical fluid extraction].
2006-08
Determination of phillyrin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies.
2006-05-03
Arctigenin from Fructus Arctii is a novel suppressor of heat shock response in mammalian cells.
2006
A high performance liquid chromatography method for the simultaneous determination of arctiin, chlorogenic acid and glycyrrhizin in a Chinese proprietary medicine.
2005-09-15
[Dyuamical studies on metabolic chemistry of lignans from seeds of Arctium lappa].
2005-08
Lack of significant modifying effect of arctiin on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats.
2005-05-26
Isolation and identification of arctiin and arctigenin in leaves of burdock (Arctium lappa L.) by polyamide column chromatography in combination with HPLC-ESI/MS.
2005-05-11
Application of preparative high-speed counter-current chromatography for separation and purification of arctiin from Fructus Arctii.
2005-01-21
The content of lignan glycosides in Forsythia flowers and leaves.
2004-12-04
Isolation and identification of biologically active compounds from Forsythia viridissima flowers.
2004-10-16
[Clinical observation on treatment of diabetic nephropathy with compound fructus arctii mixture].
2004-07
Modulation of anti-adhesion molecule MUC-1 is associated with arctiin-induced growth inhibition in PC-3 cells.
2004-05-15
Effects of forsythia fruit extracts and lignan on lipid metabolism.
2004
Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats.
2003-10-28
Simultaneous determination of chlorogenic acid, forsythin and arctiin in Chinese traditional medicines preparation by reversed phase-HPLC.
2003-04
Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria.
2003-04
[Isolation and elucidation of chemical constituents with antiviral action from yinqiaosan on influenza virus].
2003-01
Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats.
2002
Neuroprotective dibenzylbutyrolactone lignans of Torreya nucifera.
2001-07
Effects of the lignan, arctiin, on 17-beta ethinyl estradiol promotion of preneoplastic liver cell foci development in rats.
1998-06-06
Differential in vitro anti-HIV activity of natural lignans.
1990-11-01
Patents

Sample Use Guides

STZ-induced diabetic rats were treated with arctiin at the dosage of 60 or 40 mg/kg/day via intraperitoneal injection for 8 weeks.
Route of Administration: Intraperitoneal
Arctiin treatment of 3T3-L1 pre-adipocytes markedly decreased adipogenesis in a dose-dependent manner (12.5 to 100 uM).
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:05:22 GMT 2025
Edited
by admin
on Mon Mar 31 20:05:22 GMT 2025
Record UNII
TM5RQ949K7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ARCTIIN
INCI  
INCI  
Official Name English
NSC-315527
Preferred Name English
ARCTIGENIN-4-GLUCOSIDE
Common Name English
2(3H)-FURANONE, 4-((3,4-DIMETHOXYPHENYL)METHYL)-3-((4-(.BETA.-D-GLUCOPYRANOSYLOXY)-3-METHOXYPHENYL)METHYL)DIHYDRO-, (3R-TRANS)-
Common Name English
2(3H)-FURANONE, 4-((3,4-DIMETHOXYPHENYL)METHYL)-3-((4-(.BETA.-D-GLUCOPYRANOSYLOXY)-3-METHOXYPHENYL)METHYL)DIHYDRO-, (3R,4R)-
Common Name English
ARCTII
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1145
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
Code System Code Type Description
PUBCHEM
100528
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
EPA CompTox
DTXSID20942519
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
NCI_THESAURUS
C93250
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
MESH
C077992
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
FDA UNII
TM5RQ949K7
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
NSC
315527
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
WIKIPEDIA
ARCTIIN
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
CAS
20362-31-6
Created by admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
TARGET -> AGONIST
PARENT -> CONSTITUENT ALWAYS PRESENT
36% Cell growth rate of M1 cells at 50 uM of compound vs control
Related Record Type Details
ACTIVE MOIETY